Prime Medicine, Inc. Share Price: PRME (Prime Medicine, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Prime Medicine, Inc. share price today?

Accepted Answer

Prime Medicine, Inc. (PRME) share price today is {{live_price}}.

Question 2

Can Indians buy Prime Medicine, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Prime Medicine, Inc. (PRME) from India.

With INDmoney, you can buy Prime Medicine, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Prime Medicine, Inc. at zero transaction cost.

Question 3

How can I buy Prime Medicine, Inc. shares from India?

Accepted Answer

It is very easy to buy Prime Medicine, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Prime Medicine, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Prime Medicine, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Prime Medicine, Inc. stocks?

Accepted Answer

To start investing in Prime Medicine, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Prime Medicine, Inc.

Accepted Answer

Today’s highest price of Prime Medicine, Inc. (PRME) is {{1_rba_end}}.

Today’s lowest price of Prime Medicine, Inc. (PRME) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Prime Medicine, Inc.

Accepted Answer

Today's market capitalisation of Prime Medicine, Inc. PRME is 456.1M

Question 8

What is the 52 Week High and Low Range of Prime Medicine, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Prime Medicine, Inc. is down from its 52 Week High?

Accepted Answer

Prime Medicine, Inc. (PRME) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Prime Medicine, Inc. is up from its 52 Week low?

Accepted Answer

Prime Medicine, Inc. (PRME) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Prime Medicine, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Prime Medicine, Inc.

Accepted Answer

Dr. Keith Michael Gottesdiener M.D., Ph.D. is the current Chief Executive Officer (CEO) of Prime Medicine, Inc..

Period	Prime Medicine, Inc.	Index (Russel 2000)
3 Months	-19.19%	0.0%
6 Months	-8.37%	0.0%
1 Year	-37.34%	0.0%
3 Years	-71.5%	-23.0%

Market Capitalization	456.1M
Book Value	$1.69
Earnings Per Share (EPS)	-2.17
Wall Street Target Price	12.8

Profit Margin	0.0%
Operating Margin TTM	-35535.53%

Return On Assets TTM	-48.56%
Return On Equity TTM	-99.58%

Revenue TTM	591.0K
Revenue Per Share TTM	0.01
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	-86.7M
EBITDA	-204.7M
Diluted Eps TTM	-2.17
Quarterly Earnings Growth YOY	0.0

Prime Medicine, Inc. (PRME)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Vs ALNY

Institutional Holdings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-1.73
EPS Estimate Next Year	-1.41
EPS Estimate Current Quarter	-0.4
EPS Estimate Next Quarter	-0.41

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Prime Medicine, Inc.	21.67%	-8.37%	-37.34%	-71.5%	-71.5%
Regeneron Pharmaceuticals, Inc.	-9.28%	10.06%	24.53%	74.0%	232.45%
Novo Nordisk A/s	-4.54%	-5.72%	21.59%	126.2%	349.01%
Alnylam Pharmaceuticals, Inc.	8.87%	102.98%	82.67%	44.83%	241.09%
Vertex Pharmaceuticals Incorporated	5.0%	20.77%	31.37%	158.16%	163.17%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Prime Medicine, Inc.	NA	NA	NA	-1.73	-1.0	-0.49	NA	1.69
Regeneron Pharmaceuticals, Inc.	26.41	26.41	1.37	44.9	0.17	0.08	NA	261.41
Novo Nordisk A/s	40.21	40.21	1.81	3.36	0.89	0.23	0.01	25.24
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-2.42	-15.01	0.02	NA	-0.02
Vertex Pharmaceuticals Incorporated	32.84	NA	0.59	0.18	-0.03	0.13	NA	57.26

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Prime Medicine, Inc.	Buy	$456.1M	-71.5%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$110.0B	232.45%	26.41	32.04%
Novo Nordisk A/s	Buy	$529.8B	349.01%	40.21	34.84%
Alnylam Pharmaceuticals, Inc.	Buy	$38.1B	241.09%	NA	-3.11%
Vertex Pharmaceuticals Incorporated	Buy	$128.7B	163.17%	32.84	-4.74%

Organization	Prime Medicine, Inc.
Employees	234
CEO	Dr. Keith Michael Gottesdiener M.D., Ph.D.
Industry	Miscellaneous